Replication data for: Identifying Industry Margins with Price Constraints: Structural Estimation on Pharmaceuticals
- Dubois, Pierre
- Lasio, Laura
AbstractWe develop a structural model to investigate the effects of pharmaceutical price regulation on demand and on manufacturers' price-setting behavior in France. We estimate price-cost margins in a regulated market with price constraints and infer whether these constraints are binding, exploiting cost restrictions across drugs, which come from observing the same drugs in potentially price-constrained markets (France) and in markets where prices are unregulated (US and Germany). Our counterfactual simulations suggest that price constraints generated modest savings for anti-ulcer drugs in 2003–2013 (2 percent of total expenses), relative to a free pricing scenario, and shifted consumption from generic to branded drugs.
Is supplement to
DOI: 10.1257/aer.20140202 (Text)
Dubois, Pierre, and Laura Lasio. “Identifying Industry Margins with Price Constraints: Structural Estimation on Pharmaceuticals.” American Economic Review 108, no. 12 (December 2018): 3685–3724. https://doi.org/10.1257/aer.20140202.
- ID: 10.1257/aer.20140202 (DOI)
Update Metadata: 2020-05-18 | Issue Number: 2 | Registration Date: 2019-10-12